Screening Compounds Based on the Broad Institute Repurposing Set

The National Center for Advancing Translational Sciences (NCATS), within the National Institutes of Health (NIH), requires a curated collection of screening compounds based on the Broad Institute Repurposing Set. These are highly optimized small molecules, FDA-approved drugs, clinical trial drugs, and pre-clinical tool compounds with a companion information resource. The entire set has more than 6,000 compounds and NCATS seeks to purchase a curated collection as large as possible based on this Broad Institute Repurposing Set.

NCATS requires a compound library based on the Broad Institute Repurposing Set, as large as possible but with a minimum of 6,000 compounds, .... Read More